Docoh
Loading...

31 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
20 Sep 21
Definitive proxy
2:51pm
ability to attract, retain and motivate highly-skilled scientific, commercial and managerial employees, and if this proposal is not approved by our
PRE 14A
PCSA Processa Pharmaceuticals Inc
1 Sep 21
Preliminary proxy
4:46pm
to attract, retain and motivate highly-skilled scientific, commercial and managerial employees, and if this proposal is not approved by our stockholders
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
“Summary Compensation Table.” Overview of Our Executive Compensation Philosophy and Design We believe that a skilled, experienced and dedicated
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
Executive Compensation Philosophy and Design We believe that a skilled, experienced and dedicated executive and senior management team is essential
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
, for or without cause. Our success also depends on our ability to continue to attract, retain and motivate highly skilled junior, mid-level and senior … personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new or next generation product candidates
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
choose to operate in the future. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability … highly skilled junior, mid-level and senior managers as well as junior, mid-level and senior scientific and medical and scientific personnel. We
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new or next … of any of our other employees. Our success also depends on our ability to continue to attract, retain and motivate highly skilled junior, mid-level
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new or next generation product candidates … success also depends on our ability to continue to attract, retain and motivate highly skilled junior, mid-level and senior managers as well as junior
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
in the future. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new … or the lives of any of our other employees. Our success also depends on our ability to continue to attract, retain and motivate highly skilled junior, mid
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new or next generation product … employees. Our success also depends on our ability to continue to attract, retain and motivate highly skilled junior, mid-level and senior managers as well
S-1
PCSA Processa Pharmaceuticals Inc
13 Dec 19
IPO registration
5:32pm
skilled personnel, our ability to identify and develop new or next generation product candidates will be impaired, could result in loss of markets … highly skilled junior, mid-level and senior managers as well as junior, mid-level and senior scientific and medical and scientific personnel. We
10-K/A
2018 FY
PCSA Processa Pharmaceuticals Inc
5 Apr 19
Annual report (amended)
9:40pm
skilled and experienced personnel, but competition for personnel is intense and there can be no assurance that we will be able to attract and retain … by insurance. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new
10-K
2018 FY
PCSA Processa Pharmaceuticals Inc
28 Mar 19
Annual report
5:25pm
skilled and experienced personnel, but competition for personnel is intense and there can be no assurance that we will be able to attract and retain … by insurance. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new
424B3
PCSA Processa Pharmaceuticals Inc
9 Nov 18
Prospectus supplement
5:04pm
to recruit additional highly skilled personnel, our ability to identify and develop new or next generation product candidates will be impaired, could result … , retain and motivate highly skilled junior, mid-level and senior managers as well as junior, mid-level and senior scientific and medical and scientific
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Oct 18
IPO registration (amended)
4:19pm
management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new or next generation product … on our ability to continue to attract, retain and motivate highly skilled junior, mid-level and senior managers as well as junior, mid-level
S-1/A
PCSA Processa Pharmaceuticals Inc
9 Oct 18
IPO registration (amended)
5:32pm
skilled personnel, our ability to identify and develop new or next generation product candidates will be impaired, could result in loss of markets … highly skilled junior, mid-level and senior managers as well as junior, mid-level and senior scientific and medical and scientific personnel. Because
S-1/A
PCSA Processa Pharmaceuticals Inc
13 Sep 18
IPO registration (amended)
8:00pm
or covered by insurance. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify … of our other employees. Our success also depends on our ability to continue to attract, retain and motivate highly skilled junior, mid-level and senior
S-1
PCSA Processa Pharmaceuticals Inc
29 Jul 18
IPO registration
8:00pm
highly skilled personnel, our ability to identify and develop new or next generation product candidates will be impaired, could result in loss of markets … highly skilled junior, mid-level and senior managers as well as junior, mid-level and senior scientific and medical and scientific personnel
10-K/A
2017 FY
PCSA Processa Pharmaceuticals Inc
16 Apr 18
Annual report (amended)
8:00pm
believe that our relations with our employees is good. We believe that we have been successful in attracting skilled and experienced personnel … or covered by insurance. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify
10-K
2017 FY
PCSA Processa Pharmaceuticals Inc
15 Apr 18
Annual report
8:00pm
employees is good. We believe that we have been successful in attracting skilled and experienced personnel, but competition for personnel is intense … personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new or next generation product candidates